Suppr超能文献

毛细胞型星形细胞瘤具有与端粒相关的早幼粒细胞白血病小体,但不存在端粒的替代性延长。

Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres.

机构信息

Department of Pathology, Dunedin School of Medicine, PO Box 913, University of Otago, Dunedin, New Zealand.

出版信息

Am J Pathol. 2010 Dec;177(6):2694-700. doi: 10.2353/ajpath.2010.100468. Epub 2010 Oct 29.

Abstract

Telomere maintenance by either telomerase activity or the recombination-mediated alternative lengthening of telomeres (ALT) mechanism is a hallmark of cancer. Tumors that use ALT as their telomere maintenance mechanism are characterized by long telomeres of great heterogeneity in length and by specific nuclear structures of co-localized promyelocytic leukemia protein and telomere DNA, called ALT-associated promyelocytic leukemia bodies (APBs). Recent advances have revealed a direct role for APBs in telomere recombination in ALT-positive cells. In this study, we investigated the possibility that APBs could occur before the long 'alternatively' lengthened telomeres arise, particularly in low-grade tumors. We measured APBs, telomere length, and telomerase activity in 64 astrocytomas inclusive of grade 1-4 tumors. Almost all grade 1-3 tumors (93%) were APB-positive using published criteria. Grade 2-3 APB-positive tumors also had long telomeres and were confirmed as ALT positive. However, grade 1 tumors lacked long telomeres and were therefore classified as ALT negative, but positive for telomere-associated promyelocytic leukemia bodies (TPB). This is the first report of a TPB-positive but ALT-negative tumor, and suggests that low-grade tumors have the foundation for recombinational telomere repair, as in ALT. Further work is warranted to characterize the TPB-positive phenotype in other early malignancies, as well as to determine whether TPBs predispose to telomere maintenance by ALT.

摘要

端粒维持要么通过端粒酶活性,要么通过重组介导的端粒延长的替代途径(ALT)机制,这是癌症的一个标志。使用 ALT 作为端粒维持机制的肿瘤的特点是端粒很长,长度具有很大的异质性,并且存在特定的核结构,其中协同定位的早幼粒细胞白血病蛋白和端粒 DNA 称为 ALT 相关早幼粒细胞白血病体(APB)。最近的进展揭示了 APB 在 ALT 阳性细胞中的端粒重组中具有直接作用。在这项研究中,我们研究了 APB 可能在长的“替代性”延长的端粒出现之前发生的可能性,特别是在低级别肿瘤中。我们测量了 64 例星形细胞瘤中的 APB、端粒长度和端粒酶活性,包括 1-4 级肿瘤。使用已发表的标准,几乎所有的 1-3 级肿瘤(93%)都是 APB 阳性。2-3 级 APB 阳性肿瘤也具有长的端粒,并且被确认为 ALT 阳性。然而,1 级肿瘤缺乏长的端粒,因此被归类为 ALT 阴性,但端粒相关早幼粒细胞白血病体(TPB)阳性。这是首次报道 TPB 阳性但 ALT 阴性的肿瘤,表明低级别肿瘤具有 ALT 中重组性端粒修复的基础。需要进一步的工作来描述其他早期恶性肿瘤中的 TPB 阳性表型,并确定 TPB 是否易发生 ALT 介导的端粒维持。

相似文献

引用本文的文献

10
Pathological and molecular advances in pediatric low-grade astrocytoma.小儿低度星形细胞瘤的病理和分子进展。
Annu Rev Pathol. 2013 Jan 24;8:361-79. doi: 10.1146/annurev-pathol-020712-164009. Epub 2012 Oct 29.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验